New

AI v2.0 Beta Launched. Experience the future of pharmaceutical care.

Try Now
Drug info language
Switches all medical info on this page (labels, indications, leaflet) without changing the rest of the interface.
Highly Regulated (List I)Translated

GAM-COVID-VAC COMBINATION VECTOR VACCINE TO PREVENT CORONAVIRAL INFECTION CAUSED BY SARS-COV-2 VIRUS

0,5ML/DOSE (composant I) et 0,5ML/DOSE (composant II)/IM Injectable Solution/VACCIN POUR LA PREVENTION DU CORONAVIRUS COVID-19 (NOM INTERNATIONAL NON EXCLUSIF)
FSBI N F GAMALEYA RCEM OF THE MINISTRY OF HEALTH OF RUSSIA
ManufacturerVerified lab

FSBI N F GAMALEYA RCEM OF THE MINISTRY OF HEALTH OF RUSSIA

Public retail price
N/ADZD

Identification

Active ingredient (INN)
VACCIN POUR LA PREVENTION DU CORONAVIRUS COVID-19 (NOM INTERNATIONAL NON EXCLUSIF)
Internal code
13 U 504
Country of Origin
Russia
Pharmaceutical form
IM Injectable Solution
Prescription List
Highly Regulated (List I)
Packaging
b/01 flacon (composant i)/b/01 flacon (composant ii) ou b/05 ampoule. (composant i)/b/05 ampoule. (composant ii)
GAM-COVID-VAC COMBINATION VECTOR VACCINE TO PREVENT CORONAVIRAL INFECTION CAUSED BY SARS-COV-2 VIRUS
Clinical View
Highly Regulated (List I)

DAWA Clinical Workbench v2.0

Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.

Associated Conditions

Children under 12 years of age Pregnancy Associated chronic pathology Elderly Thrombocytopenia Treatment with anticoagulant in progress Coagulation disorder Concomitant vaccination.

Adverse Effects

  • Liver test increased (Very common)
  • White Globules decreased (Very common)
  • Depletion hyponatraemia (Rare)
  • ASAT (increase)
  • Neutropenia ALT (increase)
  • Rash (Common)
  • Hyperhidrosis (Uncommon)
  • Fatigue (Very common)
  • Asthenia (Uncommon)
  • Frisher (Common)
  • Fever (Very common)
  • Peripheral edema (Uncommon)
  • Pain Lymphadenopathy (Common)
  • Thrombocytopenia (Uncommon)
  • Lymphopenia Leucopenia
  • Injection site reaction (Very common)
  • Erythema at the injection site Pain at injection site
  • Injection site sensitivity Injection site induration Swelling at the injection site
  • Appetite decreased (Uncommon)
  • Conjunctival hyperaemia (Uncommon)
  • Eye pain (Common)
  • Tinnitus (Uncommon)
  • Feeling dizzy (Common)
  • Mental confusion (Rare)
  • Syncope (Uncommon)
  • Malaise (Uncommon)
  • Nausea (Very common)
  • Diarrhoea (Common)
  • Vomiting (Common)
  • Muscle pain (Very common)
  • Joint pain (Very common)
  • Sleeping (Common)
  • Arthritis Headache (Very common)
  • Paraesthesia (Uncommon)
  • Aseptic meningitis Encephalitis Neurological disorder Encephalopathy Dyspnoea (Uncommon).

Alternatives